|
|
|
|
|
|
|
|
Journal of Ovarian Research - open access
Background
The frequency of BRCA1 and BRCA2 mutations in ovarian cancer patients varies depending
on histological subtype and population investigated. The six most commonly recurring
BRCA1 and BRCA2 mutations previously identified in a founder French Canadian population
were investigated in 439 histologically defined ovarian, fallopian tube and primary
peritoneal cancer cases that were ascertained at one hospital servicing French Canadians.
To further assess the frequency of BRCA1/BRCA2 mutations, a defined subgroup of 116
cases were investigated for all mutations previously reported in this population.
Conclusions
Our results reaffirm that specific BRCA1 and BRCA2 mutations found previously to recur
in French Canadian breast cancer and breast-ovarian cancer families, also recur in
women with ovarian cancer not selected for family history of cancer. The high frequency
of mutation carriers rationalizes genetic testing of ovarian cancer patients in this
demographically defined population.
........During the course of this investigation
the Society for Gynecologic Oncology issued a clinical practice statement encouraging
the medical community to offer genetic counselling and testing to all women with ovarian,
fallopian tube and peritoneal carcinoma (www.sgo.org webcite), but The Society of Gynecologic Oncology of Canada (www.g-o-c.org webcite) has yet to propose its own recommendations......
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.